Wegovy vs Zepbound for Women Over 50: Which Wins?

If you're a woman over 50 considering GLP-1 medication, you've likely noticed that weight feels different now than it did a decade ago. The rules seem to have changed. What worked before doesn't work anymore. And now you're trying to choose between two medications with similar-sounding names but different track records.

Let's cut through the confusion. Both Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved for weight management, and both can be remarkably effective. But for women navigating menopause, hormonal shifts, and the metabolic changes that come with your 50s and beyond, there are important differences worth understanding.

What Makes These Medications Different?

Wegovy and Zepbound are both injectable medications you take once weekly, but they work through slightly different mechanisms in your body.

Wegovy contains semaglutide, which mimics a single hormone called GLP-1 (glucagon-like peptide-1). This hormone helps regulate your appetite, slows digestion, and signals to your brain that you're satisfied after eating. It's been on the market longer, with years of research behind it.

Zepbound contains tirzepatide, which is a dual-action medication. It mimics both GLP-1 and a second hormone called GIP (glucose-dependent insulinotropic polypeptide). This double approach may offer additional metabolic benefits, though it's the newer kid on the block, approved for weight loss in late 2023.

How They Perform for Women Over 50

Here's what matters most: do they actually work when your metabolism has shifted gears?

The clinical trials show impressive results for both medications, though Zepbound edges ahead slightly in the numbers. In studies, people taking Wegovy lost an average of 15-17% of their body weight over 68 weeks. Those taking Zepbound lost an average of 18-22% of their body weight over a similar timeframe.

But here's the honest truth: individual results vary widely, and being over 50 doesn't disqualify you from excellent outcomes. In fact, many women in this age group report that these medications finally gave them a tool that works with their changing body rather than against it.

What About Menopause and Hormones?

This is where the conversation gets personal. During and after menopause, declining estrogen affects how your body stores fat, maintains muscle, and responds to insulin. You're not imagining it—your body genuinely processes food and stores energy differently.

Neither Wegovy nor Zepbound directly replaces hormones, but both can help counteract some metabolic effects of hormonal changes. They improve insulin sensitivity, reduce appetite, and help regulate blood sugar—all things that become more challenging after menopause.

Some women report that these medications help reduce the abdominal weight gain that's so common during this transition. While we don't yet have head-to-head studies specifically in postmenopausal women, both medications have shown effectiveness across age groups in clinical trials.

Side Effects: What to Really Expect

Let's be honest about the not-so-fun parts. Both medications can cause digestive side effects, especially when you're starting out or increasing your dose.

Common side effects for both include nausea, occasional vomiting, diarrhea, constipation, and stomach discomfort. These typically improve over time as your body adjusts. Many women find that eating smaller portions, avoiding fatty foods, and staying hydrated helps minimize these effects.

Zepbound, because of its dual-action mechanism, may cause slightly more gastrointestinal upset for some people, though this isn't universal. Some women tolerate it beautifully; others find Wegovy gentler on their system.

One consideration for women over 50: both medications can contribute to muscle loss along with fat loss. This matters more as we age because preserving muscle mass supports metabolism, bone health, and overall vitality. Pairing either medication with resistance training and adequate protein intake is crucial.

Dosing and How They're Taken

Both Wegovy and Zepbound are self-injected once weekly using a pre-filled pen. The injection is subcutaneous (just under the skin), typically in your abdomen, thigh, or upper arm. Most women find the process easier than they anticipated.

Wegovy starts at a low dose (0.25 mg) and gradually increases over several months to a maintenance dose of 2.4 mg weekly. This slow titration helps your body adjust and minimizes side effects.

Zepbound follows a similar approach, starting at 2.5 mg and increasing every four weeks, with a maximum dose of 15 mg weekly. The dosing schedule is designed to help you ease into the medication.

Cost and Accessibility Considerations

Here's where reality hits hard. Both brand-name medications are expensive—often $1,000 or more per month without insurance coverage. Insurance coverage for weight management medications remains inconsistent, and many plans still don't cover them.

This is where compounded versions of semaglutide and tirzepatide have created new options. While compounded versions aren't identical to the brand-name medications, they contain the same active ingredients and offer a more accessible price point for many women.

Which One Actually Wins for Women Over 50?

If we're being completely honest, there's no universal winner. The "best" choice depends on your individual body, medical history, and how you respond.

Zepbound shows slightly higher average weight loss in studies and may offer additional metabolic benefits through its dual-action mechanism. If maximum weight loss is your primary goal and you tolerate the medication well, it might have an edge.

Wegovy has a longer track record with more years of safety data. If you prefer a medication that's been studied longer or if you're sensitive to side effects, it might be the better starting point.

For women over 50 specifically, both medications address the key challenges: appetite regulation that works despite hormonal changes, improved insulin sensitivity, and meaningful weight loss that can reduce risks for heart disease, diabetes, and other age-related conditions.

For Women

If you're dealing with postmenopausal weight gain, focus on the bigger picture beyond just the scale. Both medications can help, but pairing them with strength training is especially important to preserve muscle mass and bone density. Talk with your doctor about monitoring bone health and consider whether you're also addressing other menopausal symptoms that might affect your overall wellness.

For Men

While this article focuses on women over 50, men in this age group also experience metabolic changes, though typically more gradually. Both medications work effectively for men, often with similar or slightly better weight loss outcomes. The same principles apply: combine medication with resistance training to preserve muscle mass, which declines with age in men too.

From the Ozari Care Team

Start low and go slow, regardless of which medication you choose. We've seen countless women over 50 achieve excellent results with both semaglutide and tirzepatide, but rushing the dose increases often backfires with unnecessary side effects. Give your body time to adjust, prioritize protein at every meal, and remember that this is a tool—not a magic solution that works independently of other healthy habits.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team — licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 25, 2026